Shandong Kexing Bioproducts Co,.Ltd (688136.SS)
CNY 38.16
(1.46%)
CNY 38.16
(1.46%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -190.29 Million CNY | -104.23% |
| 2022 | -92.82 Million CNY | -196.23% |
| 2021 | 96.46 Million CNY | -30.67% |
| 2020 | 139.13 Million CNY | -12.94% |
| 2019 | 159.81 Million CNY | 69.72% |
| 2018 | 94.16 Million CNY | 58.55% |
| 2017 | 59.39 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 5.3 Million CNY | 1107.56% |
| 2024 Q1 | 12.4 Million CNY | 109.44% |
| 2024 Q2 | -526.11 Thousand CNY | -104.24% |
| 2023 Q2 | -38.79 Million CNY | -293.48% |
| 2023 FY | -189.57 Million CNY | -104.23% |
| 2023 Q3 | -6.75 Million CNY | 82.59% |
| 2023 Q1 | -9.85 Million CNY | 71.72% |
| 2023 Q4 | -131.44 Million CNY | -1846.39% |
| 2022 Q3 | -60.46 Million CNY | -130.66% |
| 2022 Q2 | -26.21 Million CNY | -190.05% |
| 2022 Q1 | 29.1 Million CNY | 37.62% |
| 2022 FY | -92.82 Million CNY | -196.23% |
| 2022 Q4 | -34.85 Million CNY | 42.34% |
| 2021 FY | 96.46 Million CNY | -30.67% |
| 2021 Q3 | 14.56 Million CNY | 2.66% |
| 2021 Q4 | 21.15 Million CNY | 45.26% |
| 2021 Q1 | 46.56 Million CNY | 115.04% |
| 2021 Q2 | 14.18 Million CNY | -69.54% |
| 2020 Q3 | 22.93 Million CNY | 151.62% |
| 2020 FY | 139.13 Million CNY | -12.94% |
| 2020 Q4 | 21.65 Million CNY | -5.59% |
| 2020 Q2 | 9.11 Million CNY | -89.33% |
| 2020 Q1 | 85.43 Million CNY | 110.83% |
| 2019 Q3 | 29.3 Million CNY | 0.0% |
| 2019 FY | 159.81 Million CNY | 69.72% |
| 2019 Q4 | 40.52 Million CNY | 38.26% |
| 2018 FY | 94.16 Million CNY | 58.55% |
| 2017 FY | 59.39 Million CNY | 0.0% |